Patten & Patten Inc Dexcom Inc Transaction History

Patten & Patten Inc

  • $1.42 Billion
  • Q1 2025

A detailed history of Patten & Patten Inc transactions in Dexcom Inc stock. As of the latest transaction made, Patten & Patten Inc holds 77,958 shares of DXCM stock, worth $6.63 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
77,958
Previous 74,811 4.21%
Holding current value
$6.63 Million
Previous $5.82 Million 8.51%
% of portfolio
0.38%
Previous 0.41%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025
BUY
$67.74 - $90.75 $213,177 - $285,590
3,147 Added 4.21%
77,958 $5.32 Million
Q4 2024

Feb 10, 2025
BUY
$65.68 - $81.01 $234,477 - $289,205
3,570 Added 5.01%
74,811 $5.82 Million
Q3 2024

Nov 04, 2024
BUY
$64.0 - $116.06 $1.51 Million - $2.74 Million
23,568 Added 49.44%
71,241 $4.77 Million
Q2 2024

Aug 13, 2024
SELL
$110.31 - $140.45 $75,672 - $96,348
-686 Reduced 1.42%
47,673 $5.41 Million
Q1 2024

May 10, 2024
BUY
$114.22 - $140.1 $255,510 - $313,403
2,237 Added 4.85%
48,359 $6.71 Million
Q4 2023

Jan 23, 2024
BUY
$75.49 - $124.16 $62,279 - $102,432
825 Added 1.82%
46,122 $5.72 Million
Q3 2023

Oct 27, 2023
SELL
$86.06 - $137.93 $108,607 - $174,067
-1,262 Reduced 2.71%
45,297 $4.23 Million
Q2 2023

Jul 14, 2023
SELL
$112.47 - $130.98 $106,846 - $124,430
-950 Reduced 2.0%
46,559 $5.98 Million
Q1 2023

Apr 25, 2023
SELL
$104.0 - $122.92 $10,400 - $12,292
-100 Reduced 0.21%
47,509 $5.52 Million
Q4 2022

Feb 01, 2023
SELL
$84.98 - $122.67 $78,181 - $112,856
-920 Reduced 1.9%
47,609 $5.39 Million
Q3 2022

Oct 19, 2022
BUY
$76.35 - $94.18 $104,828 - $129,309
1,373 Added 2.91%
48,529 $3.91 Million
Q2 2022

Aug 02, 2022
BUY
$67.99 - $132.89 $2.4 Million - $4.69 Million
35,322 Added 298.48%
47,156 $3.52 Million
Q1 2022

Apr 25, 2022
BUY
$94.08 - $130.2 $28,976 - $40,101
308 Added 2.67%
11,834 $6.05 Million
Q4 2021

Jan 26, 2022
SELL
$129.87 - $162.82 $44,805 - $56,172
-345 Reduced 2.91%
11,526 $6.19 Million
Q3 2021

Oct 22, 2021
SELL
$106.71 - $143.18 $24,436 - $32,788
-229 Reduced 1.89%
11,871 $6.49 Million
Q2 2021

Jul 13, 2021
SELL
$80.99 - $107.93 $14,983 - $19,967
-185 Reduced 1.51%
12,100 $5.17 Million
Q1 2021

Apr 23, 2021
SELL
$84.79 - $104.74 $13,566 - $16,758
-160 Reduced 1.29%
12,285 $4.42 Million
Q3 2020

Oct 08, 2020
SELL
$95.51 - $112.95 $31,040 - $36,708
-325 Reduced 2.55%
12,445 $5.13 Million
Q2 2020

Jul 21, 2020
SELL
$62.68 - $105.34 $68,195 - $114,609
-1,088 Reduced 7.85%
12,770 $5.18 Million
Q1 2020

Apr 16, 2020
SELL
$47.79 - $75.63 $2,628 - $4,159
-55 Reduced 0.4%
13,858 $3.73 Million
Q4 2019

Jan 13, 2020
SELL
$36.62 - $57.29 $10,070 - $15,754
-275 Reduced 1.94%
13,913 $3.04 Million
Q3 2019

Oct 15, 2019
BUY
$35.53 - $43.8 $17,054 - $21,024
480 Added 3.5%
14,188 $2.12 Million
Q2 2019

Jul 11, 2019
BUY
$27.84 - $38.92 $56,654 - $79,202
2,035 Added 17.43%
13,708 $2.05 Million
Q1 2019

Apr 23, 2019
SELL
$28.07 - $38.18 $31,999 - $43,525
-1,140 Reduced 8.9%
11,673 $1.39 Million
Q4 2018

Jan 17, 2019
SELL
$26.99 - $37.37 $194,516 - $269,325
-7,207 Reduced 36.0%
12,813 $1.54 Million
Q3 2018

Oct 17, 2018
SELL
$23.35 - $36.72 $81,841 - $128,703
-3,505 Reduced 14.9%
20,020 $2.86 Million
Q2 2018

Jul 18, 2018
BUY
$17.54 - $25.22 $40,342 - $58,006
2,300 Added 10.84%
23,525 $2.23 Million
Q1 2018

Apr 20, 2018
BUY
$13.06 - $18.54 $15,345 - $21,784
1,175 Added 5.86%
21,225 $1.57 Million
Q4 2017

Jan 22, 2018
SELL
$11.12 - $15.38 $331,987 - $459,169
-29,855 Reduced 59.82%
20,050 $1.15 Million
Q3 2017

Oct 12, 2017
BUY
$11.36 - $18.98 $566,920 - $947,196
49,905
49,905 $2.44 Million

Others Institutions Holding DXCM

# of Institutions
1,083
Shares Held
362M
Call Options Held
5.4M
Put Options Held
4.3M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $32.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Patten & Patten Inc Portfolio

Follow Patten & Patten Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patten & Patten Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email